Hans Ivar Robinson
Hans Ivar Robinson has 25 years professional experience in the pharmaceutical and biotech industry including 7 years with capital investments in the life science sector. He has held several leading international positions in AstraZeneca, Pfizer and Pronova Biopharma and several chairman and non-executive positions in smaller biotech companies. His experience covers a broad specter in the pharmaceutical and biotech industry. This includes top management, marketing, sales, business development, licensing, regulatory affairs and broad experience in start-up and development of biotech companies from early pre-clincal to clinical stages. He has extensive experience working with investors and investment banks including capital raising, private placements, mergers and IPOs. He founded Birk Venture in 2010 and holds a M.Sc. from Norwegian School of Economics (NHH).
Co-investor and external partner
Per-Oluf has 27 years experience in the Pharmaceutical and Biotech industry. He has Top management experience from both small and large organization within Pfizer e.g. Country Manager in Norway /Denmark and Italy, Regional Executive Director for Central and Eastern European Region. Last year he has held the position as CEO of Pronova BioPharma AS.
His experience covers all areas of the business from R&D to running a large organization in one of Europe’s biggest market.